KAITLYN GILBERT: Open Payments
NPI 1902540156 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 18 payments from 8 companies in 2025. Trend: 2023 $308 · 2024 $603 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $195 |
| Regeneron Healthcare Solutions, Inc. | 2 | $135 |
| 3B Medical, Inc. | 4 | $48 |
| Insmed, Inc. | 1 | $32 |
| Phadia US Inc. | 1 | $22 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Breas Medical, Inc. | 1 | $11 |
Products named: DUPIXENT, TEZSPIRE, LUNA, AIRSUPRA, Arikayce, BREZTRI, ImmunoCAP, LUMRYZ.
Industry payments across PA — which companies pay providers there.
